Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 2469-2477, May 1, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vanhaesebroeck, B.
Right arrow Articles by Fiers, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanhaesebroeck, B.
Right arrow Articles by Fiers, W.

Two Discrete Types of Tumor Necrosis Factor-resistant Cells Derived from the Same Cell Line1

Bart Vanhaesebroeck2, Sigrid Van Bladel2, Anne Lenaerts3, Philip Suffys4, Rudi Beyaert3, Rudolf Lucas3, Frans Van Roy5 and Walter Fiers6

Laboratory of Molecular Biology, State University, Gent [B. V., S. V. B., A. L., P. S., R. B., F. V. R., W. F.], and Institute for Molecular Biology, Free University, Brussels [R. L.], Belgium

From the murine fibrosarcoma cell line L929s, which is sensitive to tumor necrosis factor (TNF)-mediated cell lysis, two discrete types of TNF-resistant variants were derived by TNF selection. Cells of the first type (named L929r1) were not sensitized to TNF cytotoxicity by cotreatment with either inhibitors of protein or RNA synthesis, or {gamma}-interferon, despite the presence of a functional {gamma}-interferon response. L929r1 constitutively produced TNF in the supernatant and expressed membrane-bound TNF, which was not bound to the TNF receptor. In fact, TNF receptors could not be demonstrated on L929r1 cells, not even after low pH treatment and/or incubation with antiserum to TNF. L929r1 exhibited a stable TNF-resistant phenotype in the absence of further TNF selection. No evidence could be obtained that TNF acted as an autocrine growth factor for these cells. L929r2, the second type of TNF-resistant L929 cells, became sensitive to TNF lysis in the presence of RNA or protein synthesis inhibitors, or in the presence of {gamma}-interferon. TNF induced the secretion of interleukin 6 in these cells, additionally showing that functional TNF signaling in these cells indeed takes place, but does not lead to cell lysis under normal conditions. L929r2 did not produce TNF, also not upon stimulation with exogenous TNF. The number and binding affinity of TNF receptors were not consistently different between L929s and L929r2 cells. In the absence of further TNF selection, L929r2 gradually reverted to TNF sensitivity. This sensitivity was not reversible to TNF resistance by the gene-regulatory agents 5-azacytidine or sodium butyrate. Treatment with these agents also did not affect the TNF sensitivity of L929s cells nor the TNF resistance of L929r1 and L929r2 cells. In summary, our results suggest the existence among cells of the same cell line of discrete mechanisms for acquisition of resistance to TNF-mediated cell lysis.

1 Research was supported by the Belgian ASLK, FGWO, and IUAP.

2 Research Assistants with the NFWO.

3 Supported by the IWONL.

4 Supported by the BWTK.

5 Senior Research Associate with the NFWO.

6 To whom requests for reprints should be addressed, at the Laboratory of Molecular Biology, K. L. Ledeganckstraat 35, B-9000 Gent, Belgium.

Received 10/19/90. Accepted 2/22/91.




This article has been cited by other articles:


Home page
BloodHome page
L. P. Sashchenko, E. A. Dukhanina, Y. V. Shatalov, D. V. Yashin, T. I. Lukyanova, O. D. Kabanova, E. A. Romanova, S. V. Khaidukov, A. V. Galkin, N. V. Gnuchev, et al.
Cytotoxic T lymphocytes carrying a pattern recognition protein Tag7 can detect evasive, HLA-negative but Hsp70-exposing tumor cells, thereby ensuring FasL/Fas-mediated contact killing
Blood, September 15, 2007; 110(6): 1997 - 2004.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
G. Brouckaert, M. Kalai, D. V. Krysko, X. Saelens, D. Vercammen, `M. Ndlovu, G. Haegeman, K. D'Herde, and P. Vandenabeele
Phagocytosis of Necrotic Cells by Macrophages Is Phosphatidylserine Dependent and Does Not Induce Inflammatory Cytokine Production
Mol. Biol. Cell, March 1, 2004; 15(3): 1089 - 1100.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. P. Sashchenko, E. A. Dukhanina, D. V. Yashin, Y. V. Shatalov, E. A. Romanova, E. V. Korobko, A. V. Demin, T. I. Lukyanova, O. D. Kabanova, S. V. Khaidukov, et al.
Peptidoglycan Recognition Protein Tag7 Forms a Cytotoxic Complex with Heat Shock Protein 70 in Solution and in Lymphocytes
J. Biol. Chem., January 16, 2004; 279(3): 2117 - 2124.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
M. Kalai, M. Lamkanfi, G. Denecker, M. Boogmans, S. Lippens, A. Meeus, W. Declercq, and P. Vandenabeele
Regulation of the expression and processing of caspase-12
J. Cell Biol., August 4, 2003; 162(3): 457 - 467.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
K. Heyninck, D. De Valck, W. V. Berghe, W. Van Criekinge, R. Contreras, W. Fiers, G. Haegeman, and R. Beyaert
The Zinc Finger Protein A20 Inhibits TNF-induced NF-kappa B-dependent Gene Expression by Interfering with an RIP- or TRAF2-mediated Transactivation Signal and Directly Binds to a Novel NF-kappa B-inhibiting Protein ABIN
J. Cell Biol., June 28, 1999; 145(7): 1471 - 1482.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
E. Decoster, S. Cornelis, B. Vanhaesebroeck, and W. Fiers
Autocrine Tumor Necrosis Factor (TNF) and Lymphotoxin (LT) alpha  Differentially Modulate Cellular Sensitivity to TNF/LT-alpha Cytotoxicity in L929 Cells
J. Cell Biol., December 28, 1998; 143(7): 2057 - 2065.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. Vercammen, G. Brouckaert, G. Denecker, M. Van de Craen, W. Declercq, W. Fiers, and P. Vandenabeele
Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways
J. Exp. Med., September 7, 1998; 188(5): 919 - 930.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. De Vos, V. Goossens, E. Boone, D. Vercammen, K. Vancompernolle, P. Vandenabeele, G. Haegeman, W. Fiers, and J. Grooten
The 55-kDa Tumor Necrosis Factor Receptor Induces Clustering of Mitochondria through Its Membrane-proximal Region
J. Biol. Chem., April 17, 1998; 273(16): 9673 - 9680.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Decoster, B. Vanhaesebroeck, E. Boone, S. Plaisance, K. De Vos, G. Haegeman, J. Grooten, and W. Fiers
Induction of Unresponsiveness to Tumor Necrosis Factor (TNF) after Autocrine TNF Expression Requires TNF Membrane Retention
J. Biol. Chem., February 6, 1998; 273(6): 3271 - 3277.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
V. Vandevoorde, G. Haegeman, and W. Fiers
Induced Expression of Trimerized Intracellular Domains of the Human Tumor Necrosis Factor (TNF) p55 Receptor Elicits TNF Effects
J. Cell Biol., June 30, 1997; 137(7): 1627 - 1638.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Boone, T. Vanden Berghe, G. Van Loo, G. De Wilde, N. De Wael, D. Vercammen, W. Fiers, G. Haegeman, and P. Vandenabeele
Structure/Function Analysis of p55 Tumor Necrosis Factor Receptor and Fas-associated Death Domain. EFFECT ON NECROSIS IN L929sA CELLS
J. Biol. Chem., November 22, 2000; 275(48): 37596 - 37603.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Van Huffel, F. Delaei, K. Heyninck, D. De Valck, and R. Beyaert
Identification of a Novel A20-binding Inhibitor of Nuclear Factor-kappa B Activation Termed ABIN-2
J. Biol. Chem., August 3, 2001; 276(32): 30216 - 30223.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.